North Capital »

Eli Lilly & Co. shares owned by North Capital

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by North Capital from 13F filings

Historical chart of North Capital investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by North Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by North Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $212k 230 919.77
2025-12-31 $247k 230 1074.68
2025-09-30 $176k 231 763.00
2025-06-30 $179k 230 779.53
2025-03-31 $190k 230 825.91

More positions owned by North Capital

Spdr Series Trust State Street Bloomberg 1-3 Month T-bill Etf Bloomberg 1-3 Mo (BIL)
Dimensional Etf Trust Us Core Eqt Mkt Us Core Eqt Mkt (DFAU)
Dimensional Etf Trust Intl Core Eqt Mk Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Emgr Cre Eqt Mng Emgr Cre Eqt Mng (DFAE)
Apple (AAPL)
State Street Spdr S&p 500 Etf Units Tr Unit (SPY)
Vanguard Scottsdale Funds Short-term Treasury Etf Short Term Treas (VGSH)
Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Vanguard Ultra-shorttreasury Etf Ultra-short Trea (VGUS)
Ubs Etracs Alerian Mlp Index Etn Series B Etracs Alerian M (AMUB)
Berkshire Hathaway Inc Com Usd0.0033 Class B Cl B New (BRK.B)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Vanguard Total International Stock Index Fund Vg Tl Intl Stk F (VXUS)
Amazon (AMZN)
Meta Platforms Inc Class A Cl A (META)

View all positions for North Capital

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Vanguard Capital Management
Pnc Financial Services
State Street Corporation
FMR
Capital Research Global Investors
Vanguard Portfolio Management
Geode Capital Management
Capital World Investors
Morgan Stanley
Wellington Management Company
Bank of America Corporation
State Farm Mutual Automobile Insurance Company

View all funds holding Eli Lilly & Co.